Swiss biotech MoonLake Immunotherapeutics has emerged with what it hopes is one ... Merck KGaA had been developing the drug with partner Avillion and van Amstel’s team got in touch as soon ...

There’s a new biotech on the scene after MoonLake Immunotherapeutics launched on a mission to develop sonelokimab, a potential inflammatory diseases drug in-licensed from Germany’s Merck KGaA.

With a backdrop of mounting industry disruption and transition, Pharm Exec’s latest listing of the top global biopharma sales ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

Read about Merck & Co Inc (MRK:XNYS) stock and today's latest news and financial updates.

Review the current Merck & Co Inc (MRK:XNYS) dividend yield and history to decide if MRK is the best investment for you. MRK - Merck & Co Inc Dividends | Morningstar Morningstar brands and products ...

View the latest Merck KGaA (MRK) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Looking for Saturn? On the night of May 22, the planet will be just 2°28’—or the distance of about 2.5 pinky fingers at arm’s length—away from the waning crescent moon.

ispace's HAKUTO-R Mission 2 approaches the moon on Friday, May 16, 2025. HAKUTO-R lunar lander named RESILIENCE and lunar rover TENACIOUS are expected to land on the moon on Thursday, June 05.